Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -2.1 million
▼ 259% vs 2024
Profit
Caution€ -2.7 million
▼ 146% vs 2024
Debts
Low€ 3.1 million
▲ 140% vs 2024
Obulytix from Gent, company number BE0803351624, closed financial year 2025 with a result of € -2.7 million after tax. For that financial year Obulytix recorded a gross margin of € -2.1 million and equity of € 2.2 million. Compared with financial year 2024, the result moved from € -1.1 million to € -2.7 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.
What happened at Obulytix?
What happened at Obulytix in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lisa Patel stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.7 million. Source: NBB ↗
- Philipp Müller became a director. NBB
- Niklas Czeloth stepped down as director. NBB
- Lisa Patel became a director. NBB
- Biotilia BV became a director. NBB
- Bram Perdu became a director. NBB
- Dominic De Groote became a director. NBB
In short
From € 1.1 million loss in 2024 to € 2.7 million loss in 2025.
A new publication or filing at Obulytix? We notify you, reason included.
Follow ObulytixNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Obulytix are Yves Briers, Biotilia BV, Philipp Müller, Bram Perdu, Dominic De Groote and Qbic Venture Partners III NV. The same people are also behind FlemingA, RheaVita, VoxelSensors, AnimAb and AmphiStar.
Directors
According to the 2025 annual accounts
since 2023
Managing director · represented by Kristof Van Emelen
since 2024
Philipp Müller
Director
since 2025
Bram Perdu
Director
since 2023
Dominic De Groote
Director
since 2023
Director · represented by Cédric Van Nevel
Also active at: RheaVita, VoxelSensors, AnimAb +7 more
since 2023
Lisa Patel
Director
since 2025 · until 2031
Niklas Czeloth
Director
since 2023 · until 2025
Establishments
Establishment units
Physical locations of this company
Suzanne Tassierstraat 1 box 3.4
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 16 companies are registered at this address.
VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
€ 52.6 million revenue · 2025
ORIONIS BIOSCIENCES
€ 11.6 million revenue · 2025
LO²CUS Gent
€ 1.7 million gross margin · 2024
S-Biomedic
€ 4.4 million gross margin · 2025
VIB BIO-INCUBATOR
€ 536,162 gross margin · 2025
+11 more
Details
- Company number
- 0803.351.624
- VAT number
- BE 0803.351.624
- Registered office
- Suzanne Tassierstraat 1 bus 3.4, 9052 Gent
- Names & denominations
- Obulytix
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 June 2023
- Peppol
- Active · Active since 28 Aug 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Vervaardiging van geneesmiddelen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied